Recent Updates
Recently added Catalysts
UHS

Steve Filton Chief Financial Officer

Key Takeaway: CONTACT: Steve Filton Chief Financial Officer April 27, 2015 610-768-3300 UNIVERSAL HEALTH SERVICES, INC. REPORTS 2015 FIRST QUARTER FINANCIAL RESULTS Consolidated Results of Operations, As Reported and As Adjusted Three-month periods ended March 31, 2015 and 2014:

Full Press Release Details

CONTACT: Steve Filton
Chief Financial Officer April 27, 2015
610-768-3300
UNIVERSAL HEALTH SERVICES, INC. REPORTS
2015 FIRST QUARTER FINANCIAL RESULTS
Consolidated Results of Operations, As Reported and As Adjusted Three-month periods ended March 31, 2015 and 2014:
KING OF PRUSSIA, PA Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was
$174.3 million, or $1.73 per diluted share, during the first quarter of 2015 as compared to $138.1 million, or $1.38 per diluted share, during the comparable quarter of 2014. Net revenues increased 14.8% to $2.23 billion during the first quarter of
2015 as compared to $1.94 billion during the first quarter of 2014.
For the three-month period ended March 31, 2015, our adjusted
net income attributable to UHS, as calculated on the attached Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information ( Supplemental Schedule ), increased approximately 31% to $179.5 million, or $1.78 per diluted
share, as compared to $136.7 million, or $1.36 per diluted share, during the first quarter of 2014.
As reflected on the Supplemental
Schedule, included in our reported results during the first quarter of 2015 is a net unfavorable after-tax impact of approximately $5.2 million, or $.05 per diluted share, related to the depreciation and amortization expense recorded in connection
with the implementation of electronic health records ( EHR ) applications at our acute care hospitals.
Supplemental Schedule, included in our reported results during the first quarter of 2014 was an aggregate net favorable after-tax impact of approximately $1.4 million, or $.02 per diluted share, consisting of: (i) a favorable after-tax impact
of $6.3 million, or $.07 per diluted share, resulting from a gain realized on the sale of a non-operating investment, and; (ii) a net unfavorable after-tax impact of approximately $4.9 million, or $.05 per diluted share, related to the
incentive income and depreciation and amortization expense recorded in connection with the implementation of EHR applications.
Three-month periods ended March 31, 2015 and 2014:
During the first quarter of 2015, at our acute care hospitals owned
during both periods ( same facility basis ), adjusted admissions (adjusted for outpatient activity) increased 5.7% and adjusted patient days increased 7.5%, as compared to the first quarter of 2014. Net revenues at these facilities
increased 12.2% during the first quarter of 2015 as compared to the comparable quarter of the prior year. At these facilities, net revenue per adjusted admission increased 6.1% while net revenue per adjusted patient day increased 4.4% during the
first quarter of 2015 as compared to the comparable quarter of 2014. On a same facility basis, the operating margin at our acute care hospitals increased to 21.6%
during the first quarter of 2015 as compared to 19.2% during the first quarter of 2014. We define operating margin as net revenues less salaries, wages and benefits, other operating expenses and
supplies expense (excluding the impact of EHR and other items as indicated on the Supplemental Schedules).
The increased operating
performance experienced at our acute care facilities during the first quarter of 2015, as compared to the comparable quarter in 2014, was due in part to continued improvement in general economic conditions as well as a decrease in the number of
uninsured patients treated at our hospitals. The decrease in the number of uninsured patients treated at our acute care hospitals was due primarily to the favorable impact of the Affordable Care Act which includes the expansion of Medicaid in
certain states in which we operate and the enrollment of patients in newly created commercial exchanges.
We provide care to patients who
meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in
accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts, based on gross charges, amounting to approximately $287 million and $320 million during the three-month periods ended March 31, 2015 and 2014,
respectively. The provision for doubtful accounts at our acute care hospitals decreased to approximately $124 million during the three-month period ended March 31, 2015 as compared to $182 million during the comparable quarter of 2014. During
the three-month period ended March 31, 2015, as compared to the comparable period of 2014, our acute care hospitals experienced a decrease in the aggregate of charity care, uninsured discounts and provision for doubtful accounts as a percentage
Behavioral Health Care Services Three-month periods ended March 31, 2015 and 2014:
During the first quarter of 2015, at our behavioral health care facilities on a same facility basis, adjusted admissions increased 6.0% while
adjusted patient days increased 2.6% as compared to the first quarter of 2014. At these facilities, net revenue per adjusted admission increased 0.4% while net revenue per adjusted patient day increased 3.7% during the first quarter of 2015 as
compared to the comparable quarter in 2014. On a same facility basis, our behavioral health services net revenues increased 6.3% during the first quarter of 2015, as compared to the comparable quarter in 2014, and the operating margins were
28.6% and 27.7% during the three-month periods ended March 31, 2015 and 2014, respectively.
Share Repurchase Program:
During the third quarter of 2014, our Board of Directors authorized a stock repurchase program whereby, from time to time as conditions allow,
we may spend up to $400 million to purchase shares of our Class B Common Stock on the open market or in negotiated private transactions. In conjunction with this program, during the first quarter of 2015, we repurchased 48,269 shares at an aggregate
cost of $5.6 million. Since inception of the program through March 31, 2015, we repurchased 596,461 shares at an aggregate cost of $63.6 million.
Conference call information:
will hold a conference call for investors and analysts at 9:00 a.m. eastern time on April 28, 2015. The dial-in number is 1-877-648-7971.
A live broadcast of the conference call will be available on our website at
www.uhsinc.com. A replay of the call will be available following the conclusion of the live call and will be available for one full year.
General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:
Universal Health Services, Inc. ( UHS ) is one of the nation s largest hospital companies operating through its subsidiaries
acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, Puerto Rico and the U.S. Virgin Islands. It acts as the advisor to Universal Health Realty Income Trust, a real
estate investment trust (NYSE:UHT). For additional information on the Company, visit our web site: http://www.uhsinc.com.
press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and
Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7-Forward-Looking Statements and Risk Factors in our Form 10-K for the year ended December 31,
2014), may cause the results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine our future results are beyond our capability to control or predict. These statements are subject to
risks and uncertainties and therefore actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management s view only as of the date hereof. We undertake no obligation to
revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
We believe that operating income, operating margin, adjusted net income attributable to UHS, adjusted net income attributable to UHS per
diluted share and earnings before interest, taxes, depreciation and amortization ( EBITDA ), which are non-GAAP financial measures ( GAAP is Generally Accepted Accounting Principles in the United States of America), are helpful
to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the
effect in each year of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, costs related to extinguishment of debt, gains on sales of assets and businesses, reserves for settlements, legal
judgments and lawsuits, impairments of long-lived assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these
measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange
Commission including our Report on Form 10-K for the year ended December 31, 2014. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these
measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying
calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.
We incur health-care related taxes ( Provider Taxes ) imposed by states in the form of
a licensing fee, assessment or other mandatory payment which are related to: (i) healthcare items or services; (ii) the provision of, or the authority to provide, the health care items or services, or; (iii) the payment for the health
care items or services. Such Provider Taxes are subject to various federal regulations that limit the scope and amount of the taxes that can be levied by states in order to secure federal matching funds as part of their respective state Medicaid
programs. We derive a related Medicaid reimbursement benefit from assessed Provider Taxes in the form of Medicaid claims based payment increases and/or lump sum Medicaid supplemental payments. Under these programs, including the impact of
uncompensated care and upper payment limit programs, we earned revenues (before Provider Tax assessments) of approximately $66 million and $49 million during the three-months ended March 31, 2015 and 2014, respectively. These revenues were
offset by assessments of $28 million during the first quarter of 2015 and $18 million during the first quarter of 2014, which are recorded in other operating expenses on the attached Condensed Consolidated Statement of Income. Prior to 2015, these
assessments were recorded as a reduction to our net revenues. Accordingly, to conform with current year presentation, these assessments were reclassified on our Condensed Consolidated Statement of Income for the three-months ended March 31,
Our acute care hospitals are eligible for Medicare and Medicaid EHR incentive payments upon implementation of the EHR application,
once they have demonstrated meaningful use of certified EHR technology for the applicable stage or have completed attestations to their adoption or implementation of certified EHR technology. However, there may be timing differences in the
recognition of the incentive income and expenses recorded in connection with the implementation of the EHR application which may cause material period-to-period changes in our future results of operations. Pursuant to regulations, hospitals that do
not qualify as a meaningful user of EHR by 2015 are subject to a reduced market basket update to the inpatient prospective payment system standardized amount in 2015 and each subsequent fiscal year. We believe that all of our acute care hospitals
have met the applicable meaningful use criteria and therefore are not subject to a reduced market basked update to the inpatient prospective payment standardized amount in federal fiscal year 2015. Under the HITECH Act, hospitals must continue to
meet the applicable meaningful use criteria in each fiscal year or they will be subject to a market basket update reduction in a subsequent fiscal year.
Universal Health Services, Inc.
Consolidated Statements of Income
(in thousands, except per share amounts)
Three months ended March 31,
2015 2014
Net revenues before provision for doubtful accounts $ 2,380,101 $ 2,146,498
Less: Provision for doubtful accounts 154,748 208,184
Net revenues 2,225,353 1,938,314
Operating charges:
Salaries, wages and benefits 1,031,703 935,365
Other operating expenses 505,966 399,908
Supplies expense 238,741 215,798
Depreciation and amortization 98,998 93,359
Lease and rental expense 22,891 23,338
Electronic health records incentive income 0 (430 )
1,898,299 1,667,338
Income from operations 327,054 270,976
Interest expense, net 30,037 35,193
Income before income taxes 297,017 235,783
Provision for income taxes 102,694 83,931
Net income 194,323 151,852
Less: Income attributable to noncontrolling interests 20,024 13,774
Net income attributable to UHS $ 174,299 $ 138,078
Basic earnings per share attributable to UHS (a) $ 1.76 $ 1.40
Diluted earnings per share attributable to UHS (a) $ 1.73 $ 1.38
Universal Health Services, Inc.
Footnotes to Consolidated Statements of Income
(in thousands, except per share amounts)
Three months ended March 31,
2015 2014
(a) Earnings per share calculation:
Basic and diluted:
Net income attributable to UHS $ 174,299 $ 138,078
Less: Net income attributable to unvested restricted share grants (68 ) (70 )
Net income attributable to UHS - basic and diluted $ 174,231 $ 138,008
Weighted average number of common shares - basic 98,910 98,572
Basic earnings per share attributable to UHS: $ 1.76 $ 1.40
Weighted average number of common shares 98,910 98,572
Add: Other share equivalents 1,737 1,585
Weighted average number of common shares and equiv. - diluted 100,647 100,157
Diluted earnings per share attributable to UHS: $ 1.73 $ 1.38
Universal Health Services, Inc.
Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information ( Supplemental Schedule )
For the three months ended March 31, 2015 and 2014
(in thousands, except per share amounts)
Three months ended March 31, 2015 Three months ended March 31, 2014
Net revenues before provision for doubtful accounts $ 2,380,101 $ 2,146,498
Less: Provision for doubtful accounts 154,748 208,184
Net revenues 2,225,353 100.0 % 1,938,314 100.0 %
Operating charges:
Salaries, wages and benefits 1,031,703 46.4 % 935,365 48.3 %
Other operating expenses 505,966 22.7 % 399,908 20.6 %
Supplies expense 238,741 10.7 % 215,798 11.1 %
EHR incentive income 0 0.0 % (430 ) 0.0 %
1,776,410 79.8 % 1,550,641 80.0 %
Operating income/margin ( EBITDAR ) 448,943 20.2 % 387,673 20.0 %
Lease and rental expense 22,891 23,338
Income attributable to noncontrolling interests 20,024 13,774
Earnings before, depreciation and amortization, interest expense, and income taxes ( EBITDA ) 406,028 18.2 % 350,561 18.1 %
Depreciation and amortization 98,998 93,359
Interest expense, net 30,037 35,193
Income before income taxes 276,993 222,009
Provision for income taxes 102,694 83,931
Net income attributable to UHS $ 174,299 $ 138,078
Calculation of Adjusted Net Income Attributable to UHS
Three months ended March 31, 2015 Three months ended March 31, 2014
Amount Per Diluted Share Amount Per Diluted Share
Calculation of Adjusted Net Income Attributable to UHS - including and excluding EHR impact:
Net income attributable to UHS $ 174,299 $ 1.73 $ 138,078 $ 1.38
Plus/minus adjustments:
Gain on sale of investment, net of income taxes (6,330 ) (0.07 )
Adjusted net income attributable to UHS - including Electronic Health Records ( EHR ) impact $ 174,299 $ 1.73 $ 131,748 $ 1.31
Plus/minus impact of EHR implementation:
EHR-related incentive income, pre-tax (430 )
EHR-related depreciation & amortization, pre-tax 9,306 9,290
EHR-related minority interest in earnings of consolidated entities, pre-tax (964 ) (966 )
Income tax provision on EHR-related items (3,109 ) (2,948 )
After-tax impact of EHR-related items 5,233 0.05 4,946 0.05
Adjusted net income attributable to UHS $ 179,532 $ 1.78 $ 136,694 $ 1.36
Universal Health Services, Inc.
Consolidated Statements of Comprehensive Income
Three months ended March 31,
2015 2014
Net income $ 194,323 $ 151,852
Other comprehensive income (loss):
Unrealized derivative gains (loss) on cash flow hedges 4,132 3,745
Amortization of terminated hedge (84 ) (84 )
Foreign currency translation adjustment (418 ) 0
Other comprehensive income before tax 3,630 3,661
Income tax expense related to items of other comprehensive income 1,497 1,354
Total other comprehensive income, net of tax 2,133 2,307
Comprehensive income 196,456 154,159
Less: Comprehensive income attributable to noncontrolling interests 20,024 13,774
Comprehensive income attributable to UHS $ 176,432 $ 140,385
Universal Health Services, Inc.
Condensed Consolidated Balance Sheets
March 31, 2015 December 31, 2014
Assets
Current assets:
Cash and cash equivalents $ 35,078 $ 32,069
Accounts receivable, net 1,383,964 1,282,735
Supplies 108,269 108,115
Deferred income taxes 109,402 114,565
Other current assets 80,524 77,654
Total current assets 1,717,237 1,615,138
Property and equipment 6,301,410 6,212,030
Less: accumulated depreciation (2,610,630 ) (2,532,341 )
3,690,780 3,679,689
Other assets:
Goodwill 3,297,436 3,291,213
Deferred charges 38,761 40,319
Other 340,141 348,084
$ 9,084,355 $ 8,974,443
Liabilities and Stockholders Equity
Current liabilities:
Current maturities of long-term debt $ 89,023 $ 68,319
Accounts payable and accrued liabilities 1,101,143 1,113,062
Federal and state taxes 65,106 1,446
Total current liabilities 1,255,272 1,182,827
Other noncurrent liabilities 277,617 268,555
Long-term debt 3,051,571 3,210,215
Deferred income taxes 280,662 282,214
Redeemable noncontrolling interest 254,843 239,552
UHS common stockholders equity 3,906,963 3,735,946
Noncontrolling interest 57,427 55,134
Total equity 3,964,390 3,791,080
$ 9,084,355 $ 8,974,443
Universal Health Services, Inc.
Consolidated Statements of Cash Flows
Three months ended March 31,
2015 2014
Cash Flows from Operating Activities:
Net income $ 194,323 $ 151,852
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization 98,998 93,359
Gains on sales of assets and businesses, net of losses 0 (10,134 )
Stock-based compensation expense 10,829 7,152
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable (96,972 ) (95,633 )
Accrued interest 1,117 11,063
Accrued and deferred income taxes 79,050 65,321
Other working capital accounts (29,829 ) (34,999 )
Other assets and deferred charges (234 ) 9,982
Other 17,807 (3,833 )
Accrued insurance expense, net of commercial premiums paid 22,748 21,302
Payments made in settlement of self-insurance claims (26,562 ) (20,793 )
Net cash provided by operating activities 271,275 194,639
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals (89,276 ) (92,387 )
Proceeds received from sale of assets and businesses 0 11,450
Acquisition of property and businesses (34,500 ) (3,301 )
Costs incurred for purchase and implementation of electronic health records application 0 (6,504 )
Net cash used in investing activities (123,776 ) (90,742 )
Cash Flows from Financing Activities:
Reduction of long-term debt (158,871 ) (109,054 )
Additional borrowings 20,800 11,900
Repurchase of common shares (28,767 ) (13,993 )
Dividends paid (9,899 ) (4,933 )
Issuance of common stock 1,768 1,445
Excess income tax benefits related to stock-based compensation 20,807 11,750
Profit distributions to noncontrolling interests (2,413 ) (1,989 )
Proceeds received from sale/leaseback of real property 12,551 0
Net cash used in financing activities (144,024 ) (104,874 )
Effect of exchange rate changes on cash and cash equivalents (466 ) 0
Increase (decrease) in cash and cash equivalents 3,009 (977 )
Cash and cash equivalents, beginning of period 32,069 17,238
Cash and cash equivalents, end of period $ 35,078 $ 16,261
Supplemental Disclosures of Cash Flow Information:
Interest paid $ 27,158 $ 18,893
Income taxes paid, net of refunds $ 2,876 $ 6,764
Noncash purchases of property and equipment $ 33,082 $ 49,533
Last updated: Apr 27, 2015